Clinical Applications of Botulinum Toxin in Oral and Maxillofacial Surgery: Clinical Applications of Botulinum Toxin in Oral and Maxillofacial Surgery

Ahmed Wallan  AlAhmary; Sabrin Moshabab Alqhtani; Bshayer Abdullah Alshahrani; Wadiah Abdullah Alkaram; Bayan Saeed Alhadad; Ahmed M. Elmarakby

doi:10.3889/oamjms.2020.4587

Authors

Ahmed Wallan AlAhmary Department of Oral and Maxillofacial Surgery, Al-Farabi Colleges for Dentistry and Nursing, Riyadh, Saudi Arabia
Sabrin Moshabab Alqhtani Department of Oral and Maxillofacial Surgery, Al-Farabi Colleges for Dentistry and Nursing, Riyadh, Saudi Arabia
Bshayer Abdullah Alshahrani Department of Oral and Maxillofacial Surgery, Al-Farabi Colleges for Dentistry and Nursing, Riyadh, Saudi Arabia
Wadiah Abdullah Alkaram Department of Oral and Maxillofacial Surgery, Al-Farabi Colleges for Dentistry and Nursing, Riyadh, Saudi Arabia
Bayan Saeed Alhadad Department of Oral and Maxillofacial Surgery, Al-Farabi Colleges for Dentistry and Nursing, Riyadh, Saudi Arabia
Ahmed M. Elmarakby Department of Restorative Dental Sciences, Al-Farabi Colleges for Dentistry and Nursing, Riyadh, Saudi Arabia; Department Operative Dentistry, Faculty of Dental Medicine, Al-Azhar University, Assiut Branch, Egypt

DOI:

https://doi.org/10.3889/oamjms.2020.4587

Keywords:

Botulinum toxin, Oral and maxillofacial surgery, Dentistry, Applications

Abstract

Botulinum toxin is a toxin produced by Clostridium botulinum bacteria. This toxin has eight known serotypes, among which both A and B are currently used in medicine. Its mechanism of action acts on inhibiting acetylcholine release at neuromuscular junctions following its local injection. This toxin has wide applications in dentistry in general and in oral and maxillofacial (OMF) surgery in particular. It can be applied in the management of temporomandibular joint disorders, neuropathic facial pain, facial nerve palsy, hypertrophy, and hyperactivity of masticatory muscles as examples. At present, it can be used in cosmetic treatment in the facial region to control wrinkles and asymmetry. The therapeutic effects of these toxins are temporary and relatively safe if used in an appropriate manner. This review was aimed to identify the uses of botulinum toxin in surgical and non-surgical treatment of OMF problems, the types of treatment available, and benefits of those treatments.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Oral-Maxillofacial Surgery Associates. What is Oral Maxillofacial Surgery; 2019. Available from: https://www.omsanewmexico.com/patient-information/what-is-oral-maxillofacial-surgery. [Last accessed on 2019 Feb 22]. https://doi.org/10.1201/b17980-7

Royal College of Surgeons. Oral and Maxillofacial Surgery; 2018. Available from: https://www.rcseng.ac.uk/news-and-events/media-centre/media-background-briefings-and-statistics/oraland-maxillofacial-surgery. [Last accessed on 2019 Feb 20].

Münchau A, Bhatia KP. Uses of botulinum toxin injection in medicine today. BMJ. 2000;320(7228):161-5. https://doi.org/10.1136/bmj.320.7228.161 PMid:10634738

Nigam PK, Nigam A. Botulinum toxin. Indian J Dermatol. 2010;55(1):8-14. https://doi.org/10.4103/0019-5154.60343 PMid:20418969

Edmonds K, editor. Dewhurst’s Textbook of Obstetrics and Gynaecology. Ch. 49. John Wiley and Sons; 2011. p. 540.

Başar E, Arıcı C. Use of botulinum neurotoxin in ophthalmology. Turk J Ophthalmol. 2016; 46(6):282-90. https://doi.org/10.4274/tjo.57701 PMid:28050326

Better Health Channel. Cosmetic Treatments Injectables; 2018. Available from: https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/cosmetic-treatments-injectables. [Last accessed on 2019 Feb 21].

Food and Drug Administration. Fillers; 2009. Available from: http://www.fda.gov/Medicaldevices/productsandmedicalprocedures/cosmeticdevices/wrinklefillers/default.html. [Last accessed on 2010 Feb 21].

Vedamurthy M. Standard guidelines for the use of dermal fillers. Indian J Dermatol Venereol Leprol. 2008;74(7):23-7. PMid:18688100

Sinha A, Hurakadli M, Yadav P. Botox and derma fillers: The twin face of cosmetic dentistry. Int J Contemp Dent Med Rev. 2015;2015:131214.

Bennett JD, Miller TA, Richards RS. The use of Botox® in interventional radiology. Tech Vasc Interv Radiol. 2006;9(1):36-9. PMid:17145484

Stevens RC, Evenson ML, Tepp W, DasGupta BR. Crystallization and preliminary X-ray analysis of botulinum neurotoxin Type A. J Mol Biol. 1991;222(4):877-80. https://doi.org/10.1016/0022-2836(91)90581-p PMid:10944343

O’Dell MW, Villanueva M, Creelman C, Telhan G, Nestor J, Hentel KD, et al. Detection of botulinum toxin muscle effect in humans using magnetic resonance imaging: A qualitative case series. PM R. 2017;9(12):1225-35. https://doi.org/10.1016/j.pmrj.2017.04.014 PMid:28483684

Flynn TC. Botulinum toxin: Examining duration of effect in facial aesthetic applications. Am J Clin Dermatol. 2010;11(3):183-99. PMid:20369902

França K, Kumar A, Fioranelli M, Lotti T, Tirant M, Roccia MG. The history of Botulinum toxin: from poison to beauty. Wien Med Wochenschr. 2017;167(1):46-8. https://doi.org/10.1007/s10354-017-0553-7 PMid:28299552

Sätilä H. The route of botulinum toxin from cause of food poisoning to medical remedy. Duodecim. 2014;130(15):1523-30. PMid:25211822

Erbguth FJ. From poison to remedy: The chequered history of botulinum toxin. J Neural Transm. 2008;115(4):559-65. https://doi.org/10.1007/s00702-007-0728-2 PMid:17458494

Medscape. Botulinum Toxin: Overview; 2018. Available from: https://www.emedicine.medscape.com/article/325451-overview#a2. [Last accessed on 2019 Feb 21].

Majid OW. Clinical use of botulinum toxins in oral and maxillofacial surgery. Int J Oral Maxillofac Surg. 2009;39:197-207. https://doi.org/10.1016/j.ijom.2009.10.022 PMid:19959337

Park K, Chi-Heun L, Jung-Woo L. Use of botulinum toxin a in dentistry and oral and maxillofacial surgery. J Dent Anesth Pain Med. 2016;16(3):151-7. PMid:28884147

Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol. 2000;43(2):249-59. PMid:10906647

Rho NK, Kim HS, Kim YS, Kim YJ, Kim CH, Kim YS, et al. Botulinum toxin Type A for facial wrinkles and benign masseter hypertrophy in Korean patients. Korean J Dermatol. 2010;48(10):823-31.

Dressler D, Saberi FA, Barbosa ER. Botulinum toxin: mechanisms of action. Arq Neuropsiquiatr. 2005;63(1):180-5. https://doi.org/10.1590/s0004-282x2005000100035 PMid:15830090

Montecucco C, Molgó J. Botulinal neurotoxins: Revival of an old killer. Curr Opin Pharmacol. 2005;5(3):274-9. https://doi.org/10.1016/j.coph.2004.12.006 PMid:15907915

Felber ES. Botulinum toxin in primary care medicine. J Am Osteopath Assoc. 2006;106(10):609-14. PMid:17122031

Čapek, P, Dickerson TJ. Sensing the deadliest toxin: Technologies for botulinum neurotoxin detection. Toxins (Basel). 2010;2(1):24-53. https://doi.org/10.3390/toxins2010024 PMid:22069545

Sadick NS, Matarasso SL. Comparison of botulinum toxins A and B in the treatment of facial rhytides. Dermatol Clin. 2004;22(2):221-6. https://doi.org/10.1016/s0733-8635(03)00040-8 PMid:15222583

Troung DD, Jost WH. Botulinum toxin: Clinical use (review). Parkinsonism Relat Disord. 2006;12(6):331-55. PMid:16870487

Srivastava S, Kharbanda S, Pal US, Shah V. Applications of botulinum toxin in dentistry: A comprehensive review. Natl J Maxillofac Surg. 2015;6(2):152-9. https://doi.org/10.4103/0975-5950.183860 PMid:27390488

Mazzuco R, Hexsel D. Gummy smile and botulinum toxin: A new approach based on the gingival exposure area. J Am Acad Dermatol. 2010;63(6):1042-51. https://doi.org/10.1016/j.jaad.2010.02.053 PMid:21093661

Connelly ST, Myung J, Gupta R, Tartaqlia GM, Gizdulich A, Yang J, et al. Clinical outcomes of botox injections for chronic temporomandibular disorders: Do we understand how botox works on muscle, pain and the brain? Int J Oral Medicine Surg. 2017;46(3):322-7. https://doi.org/10.1016/j.ijom.2016.11.004 PMid:27908491

Orlova OR, Akulov MA, Usachev DI, Taniashin SV, Zakharov VO, Saksonova EV, et al. The use of botulinum toxin Type A in the acute phase of facial nerve injury after neurosurgical surgery. Zh Vopr Neirokhir Im N N Burdenko. 2014;78(6):50-4. https://doi.org/10.17116/neiro201478650-54 PMid:25809169

Tater P, Pandey S. Botulinum toxin in movement disorders. Neurol India. 2018;66(7):79-89. https://doi.org/10.4103/0028-3886.226441 PMid:29503330

Bhogal PS, Hutton A, Monaghan A. A review of the current uses of botox for dentally-related procedures. Dent Update. 2006;33(3):165-8. https://doi.org/10.12968/denu.2006.33.3.165 PMid:16700273

Hegedus F, Diecidue R, Taub D, Nyirady J. Non-surgical treatment modalities of facial photodamage: Practical knowledge for the oral and maxillofacial professional. Int J Oral Maxillofac Surg. 2006;35(5):389-98. https://doi.org/10.1016/j.ijom.2005.09.011 PMid:16352420

Niamtu III J. Botulinum toxin A: A review of 1,085 oral and maxillofacial patient treatments. J Oral Maxillofac Surg. 2003;61(3):317-24. https://doi.org/10.1053/joms.2003.50069 PMid:12618971

Bentsianov B, Francis A, Blitzer A. Botulinum toxin treatment of temporo-mandibular disorders, masseteric hyper-trophy, and cosmetic masseter reduction. Oper Tech Otolaryngol Head Neck Surg. 2004;15(2):110-3. https://doi.org/10.1016/j.otot.2004.02.002

Isaac AM. Unilateral temporalis muscle hypertrophy managed with botulinum toxin Type A. Br J Oral Maxillofac Surg. 2000;38(5):571-2. https://doi.org/10.1054/bjom.2000.0298 PMid:11010798

Jaspers GW, Pijpe J, Jansma J. The use of botulinum toxin Type A in cosmetic facial procedures. Int J Oral Maxillofac Surg. 2011;40(2):127-33. https://doi.org/10.1016/j.ijom.2010.09.014 PMid:20965695

Amin V, Amin V, Swathi D, Shetty P. Enhancing the smile with botox case report. Glob J Med Res. 2014;13:15-8. 41. Tezel A, Fredrickson GH. The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther. 2008;10(1):35-42. PMid:18330796

Polo M. Botulinum toxin Type A (Botox) for the neuromuscular correction of excessive gingival display on smiling (gummy smile). Am J Orthod Dentofacial Orthop. 2008;133(2):195-203. https://doi.org/10.1016/j.ajodo.2007.04.033 PMid:18249285

Mostafa D. A Successful management of sever gummy smile using gingivectomy and botulinum toxin injection: A case report. Int J Surg Case Rep. 2018;42:169-74. https://doi.org/10.1016/j.ijscr.2017.11.055 PMid:29248835

Choi YJ, Kim JS, Gil YC, Phetudom T, Kim HJ, Tansatit T, et al. Anatomical considerations regarding the location and boundary of the depressor anguli oris muscle with reference to botulinum toxin injection. Plast Reconstr Surg. 2014;134(5):917-21. https://doi.org/10.1097/prs.0000000000000589 PMid:25347627

Ihde SK, Konstantinovic VS. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: An evidence-based review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104(2):e1-11. https://doi.org/10.1016/j.tripleo.2007.02.004 PMid:17560141

Kim HS, Yun PY, Kim YK. A clinical evaluation of botulinum toxin-a injections in the temporomandibular disorder treatment. Maxillofac Plast Reconstr Surg. 2016;38(1):5. https://doi.org/10.1186/s40902-016-0051-7 PMid:26855937

Freund B, Schwartz M. Temporal relationship of muscle weakness and pain reduction in subjects treated with botulinum toxin A. J Pain. 2003;4(3):159-65. https://doi.org/10.1054/jpai.2003.435 PMid:14622713

Ataran R, Bahramian A, Jamali Z, Pishahang V, Barzegani HS, Sarbakhsh P, Yazdani J. The role of botulinum toxin a in treatment of temporomandibular joint disorders: A review. J Dent Shiraz Univ Med Sci. 2017;18(3):157-64. PMid:29034269

D’Elia JB, Blitzer A. Temporomandibular disorders, masseteric hypertrophy, and cosmetic masseter reduction. In: Botulinum Neurotoxin for Head and Neck Disorders. Vol. 28. Thieme; 2012. p. 141-51. https://doi.org/10.1055/b-0034-84394

Kurtoglu C, Gur OH, Kurkcu M, Sertdemir Y, Guler-Uysal F, Uysal H. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement. J Oral Maxillofac Surg. 2008;66(8):1644-51. https://doi.org/10.1016/j.joms.2008.03.008 PMid:18634953

Giess R, Naumann M, Werner E, Riemann R, Beck M, Puls I, et al. Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2000;69(1):121-3. https://doi.org/10.1136/jnnp.69.1.121 PMid:10864618

Porta M, Gamba M, Bertacci G. Treatment of sialorrhea with ultrasound guided botulinum toxin Type A injections in patients with neurological disorders. J Neurol Neurosurg Psychiatry. 2001;70(4):538-54. https://doi.org/10.1136/jnnp.70.4.538 PMid:11254784

Ellies M, Laskawi R, Tormählen G, Götz W. The effect of local injection of botulinum toxin A on the parotid gland of the rat: An immunohistochemical and morphometric study. J Oral Maxillofacial Surg. 2000;58(11):1251-6. https://doi.org/10.1053/joms.2000.16625

Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG. Botulinum toxin Type A for drooling in Parkinson’s disease: A double-blind, randomized, placebo-controlled study. Mov Disord. 2006;21(5):704-7. https://doi.org/10.1002/mds.20793 PMid:16440332

Verma A, Steele J. Botulinum toxin improves sialorrhea and quality of living in bulbaramyotrophic lateral sclerosis. Muscle Nerve. 2006;34(2):235-7. https://doi.org/10.1002/mus.20545 PMid:16583370

Suskind DL, Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope. 2002;112(1):73-81. https://doi.org/10.1097/00005537-200201000-00014 PMid:11802042

Capaccio P, Torretta S, Osio M, Minorati D. Botulinum toxin therapy: A tempting tool in the management of salivary secretory disorders. Am J Otolaryngol. 2008;29(5):333-8. https://doi.org/10.1016/j.amjoto.2007.10.003 PMid:18722890

Drummond P. Mechanism of gustatory ﬂushing in Frey’s syndrome. Clin Auton Res. 2002;12:144-6. PMid:12269544

Benson J, Daugherty KK. Botulinum toxin A in the treatment of sialorrhea. Ann Pharmacother. 2007;41(1):79-85. https://doi.org/10.1345/aph.1h381 PMid:17190848

Philouze P, Vertu D, Ceruse P. Bilateral gustatory sweating in the submandibular region after bilateral neck dissection successfully treated with botulinum toxin. Br J Oral Maxillofac Surg. 2014;52(8):761-3. https://doi.org/10.1016/j.bjoms.2014.06.008 PMid:24996697

Guardiani E, Sadoughi B, Blitzer A, Sirois D. A new treatment paradigm for trigeminal neuralgia using botulinum toxin Type A. Laryngoscope. 2014;124(2):413-7. https://doi.org/10.1002/lary.24286 PMid:23818108

Borodic G, Acquadro M. Management of facial pain with botulinum toxin in a tertiary pain clinic. Naunyn Schmiedebergs Arch Phannacol. 2002;365(2):R14.

Borodic GE, Acquadro MA. The use of botulinum Toxin for the treatment of chronic facial pain. J Pain. 2002;3(1):21-7. https://doi.org/10.1054/jpai.2002.27142 PMid:14622850

Börü ÜT, Duman A, Bölük C, Duman SC, Taşdemir M. Botulinum toxin in the treatment of trigeminal neuralgia: 6-month follow-up. Medicine. 2017;96(39):e8133. https://doi.org/10.1097/md.0000000000008133 PMid:28953646

Freund BJ, Schwartz M. Treatment of chronic cervicalassociated headache with botulinum toxin A: A pilot study. Headache. 2000;40(3):231-6. https://doi.org/10.1046/j.1526-4610.2000.00033.x PMid:10759926

Toffola ED, Furini F, Redaelli C, Prestifilippo E, Bejor M. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy. Disabil Rehabil. 2010;32(17):1414-8. https://doi.org/10.3109/09638280903514697 PMid:20156046

Montoya FJ, Riddell CE, Caesar R, Hague S. Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland. Eye. 2002;16(6):705-9. https://doi.org/10.1038/sj.eye.6700230 PMid:12439663

Cabin JA, Massry GG, Azizzedah B. Botulinum toxin in the management of facial paralysis. Curr Opin Otolaryngol Head Neck Surg. 2015;23(4):272-80. https://doi.org/10.1097/moo.0000000000000176 PMid:26101876

Tan EK, Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc. 2000;131(2):211-6. PMid:10680389

Lee SJ, McCall WD Jr., Kim YK, Chung SC, Chung JW. Effect of botulinum toxin injection on nocturnal bruxism: A randomized controlled trial. Am J Phys Med Rehabil. 2010;89(1):16-23. https://doi.org/10.1097/phm.0b013e3181bc0c78 PMid:19855255

Shim YJ, Lee MK, Kato T, Park HU, Heo K, Kim ST. Effects of botulinum toxin on jaw motor events during sleep in sleep bruxism patients: A polysomnographic evaluation. J Clin Sleep Med. 2014;10(3):291-8. https://doi.org/10.5664/jcsm.3532 PMid:24634627

Charles A. Perioperative Use of Botulinum Toxins. Abstracts Toxins. Toxicon. 2008;51:44. https://doi.org/10.1016/j.toxicon.2008.04.133

Ihde S. Prophylactic use of botulinum toxin in dental implantology. CMF Implement Dir. 2007;1:29-34.

Nayyar P, Kumar P, Nayyar PV, Singh A. BOTOX: Broadening the horizon of dentistry. J Clin Diagn Res. 2014;8(12):ZE25-9. PMid:25654058

Seok H, Park YT, Kim SG, Park YW. Correction of posttraumatic anterior open bite by injection of botulinum toxin Type A into the anterior belly of the digastric muscle: Case report. J Korean Assoc Oral Maxillofac Surg. 2013;39(4):188-92. https://doi.org/10.5125/jkaoms.2013.39.4.188 PMid:24471041

Grünheid T, Langenbach GE, Korfage JA, Zentner A, van Eijden TM. The adaptive response of jaw muscles to varying functional demands. Eur J Orthod. 2009;31(6):596-612. https://doi.org/10.1093/ejo/cjp093 PMid:19656804

Poulain B, Popoff MR, Molgó J. How do the botulinum neurotoxins block neurotransmitter release: From botulism to the molecular mechanism of action. Botulinum J. 2008;1(1):14-87. https://doi.org/10.1504/tbj.2008.018951

Ting PT, Frieman A. The story of Clostridium botulinum: From food poisoning to Botox. Clin Med. 2004;4(3):258-61. PMid:15244362

Naumann M, Albanese A, Heinen F, Molenaers G, Relja M. Safety and efficacy of botulinum toxin Type A following long-term use. Eur J Neurol. 2006;13:35-40. https://doi.org/10.1111/j.1468-1331.2006.01652.x PMid:17112348

Sanjuan-Sanjuan A, Alamillos-Granados FJ, Dean-Ferrer A, de la Cruz ME, Mendez-García M, Murga-Oporto L. Electromyography assisted application of botulinum toxin in pterygoid musculature for the treatment of masticatory myofascial pain. Rev Esp Cirug Oral y Maxilofac. 2019;41(2):54-60. https://doi.org/10.20986/recom.2019.1017/2018

Cote TR, Mohan AK, Polder JA, Walton MK, Braun MM. Botulinum toxin Type A injections: Adverse events reported to the us food and drug administration in therapeutic and cosmetic cases. J Am Acad Dermatol. 2005;53:407-15. https://doi.org/10.1016/j.jaad.2005.06.011 PMid:16112345